Women In Hepatitis Africa

Email

wiha@livewellng.org

Web

http://wiha.livewellng.org

Address

Nigeria
About Women In Hepatitis Africa

Women in Hepatitis Africa WIHA was launched 12 months ago on April 26th 2017 in Lagos, Nigeria, during the 2nd Liver Health Conference #LHC2017 at which President Charles Gore of WHA gave an opening Goodwill speech.
WIHA has since then hit the ground running, with a lot of activities and programmes; collaborations and networking, including the hosting of its first biennial Regional Conference for women of Africa, focusing on Hepatitis and the Global Agenda of elimination by 2030.
Here are some of the activities of WIHA since inception:
1. AWARENESS, ADVOCACY, SCREENING AND VACCINATION:
As a new organisation barely a year old, WIHA has screened over 15,000 subjects to date, for Hepatitis B & C respectively; of which more than 60% of those screened are women. In addition to Screening, WIHA vaccinates with informed consent.

2. GEOGRAPHICAL COVERAGE:
WIHA has run its operations in 4 geopolitical zones of the country, having screened women for hepatitis in Lagos, Kaduna, Abuja, Port Harcourt, and Ibadan. In addition, WIHA has impacted at least 10 countries in Africa within a short time, having hosted and trained citizens from those countries, on Hepatitis

3. WORLD HEPATITIS DAY 2017:
On World Hepatitis Day #WHD2017 WIHA ran two concurrent and simultaneous programmes in Lagos and Abuja respectively, in partnership with its parent company LiveWell Initiative LWI, penetrating the Presidency at Aso Rock Villa and screening 150 top government functionaries and top aides at the Presidency, for Hepatitis B & C. The Advocacy at the Presidency was phenomenal and was carried to the next level when the team was invited to the Aguda House, Vice Presidents Lodge, where 85 citizens were screened.
The Wife of the Vice President of Nigeria, Mrs Dolapo Osinbajo, was honored with Membership of WIHA.
In Lagos WIHA simultaneously marked WHD2017 with a Corpoorate Health Outreach.

4. REGIONAL CONFERENCE:
As a young and budding global organisation with its Global Ambassador in the USA, and Head Office in Nigeria, WIHA hosted its inaugural Regional Conference on November 28th 2017 at Protea hotel, Ikeja GRA, Lagos Nigeria, ably supported by WHO Nigeria Office and Federal Ministry of Health Abuja. The WIHA Conference which hosted women from at least 8 African countries, will be held bienially.

5. WOMEN CHAMPIONS TRAINING #10BY20:
WIHA was able to ryn its first self-funded training for women as Hepatitis Champions, oon November 29th 2017 in Lagos Nigeria. The 100 women trainees from all disparities included pregnant women, lactating mothers, old women, young women, educated women, low literacy women, and women living with hepatitis B or C. The training which was supported by WHO with Federal Ministry of Health Director on the Faculty, was very successful. Trainees were certified and given a career organogram as Hepatitis Champions. They would form their Hepatitis Cells and become Cell Champion; and every active cell lead will be promoted to Cell Supervisor. Every Cell Supervisor will be integrated into the Teaching Faculty irrespective of their Sociodemographic status

6. WOMEN EMPOWERMENT THROUGH HEPATITIS INITIATIVES:
The women are forming their cells and we are recording great success, with low literacy women they are rallying their cell members and the educated women and healthcare professionals are doing the same. We are enhancing awareness, testing and vaccination.

7. DE-STIGMATIZATION, TREATMENT FACILITATION:
WIHA assists women living with viral hepatitis to access linkages to care through government designated treatment centres in Lagos State and Nassarawa State. The organisation automatically appoints such women as women leaders in hepatitis, to de-stigmatize them and to give them self confidence and esteem to carry on with the elimination agenda, advocacy and awareness creation.

Sign up to receive updates from WHA

Name(Required)
I would like to hear about(Required)

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

tHIS

 

IS 

 

BEN’S

 

 

 

BIG 

 

 

TEST

effective case finding strategies

Supported by Vir Biotechnology, Inc

During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.

Session Agenda

14:40 – 14:45    

Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)

14:45 – 15:05   

Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology

15:05 – 15:10    

Final remarks and close